loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 203139 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 MEGESTROL ACETATE (1)

filter

01 TWI PHARMS (1)

filter

01 SUSPENSION;ORAL (1)

filter

01 125MG/ML (1)

filter

01 USA (1)

URL Supplier Web Content
SUSPENSION;ORAL
125MG/ML
MEGESTROL ACETATE
USA
203139
2014-08-27
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 203139

Looking for CTD TGA MCC DOSSIER APPLICATION 203139 1

19

TWi Pharmaceuticals, Inc., based in China, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is MEGESTROL ACETATE, with a corresponding application number 203139 and regulatory information .

proudly manufactured in the

approval since 2014-08-27

TWi Pharmaceuticals, Inc.'s MEGESTROL ACETATE SUSPENSION;ORAL, medication with 125MG/ML of MEGESTROL ACETATE.

Post Enquiry
POST ENQUIRY